Wickramasinghe Sunitha N, Wood William G
Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.
Br J Haematol. 2005 Nov;131(4):431-46. doi: 10.1111/j.1365-2141.2005.05757.x.
The congenital dyserythropoietic anaemias (CDAs) are a heterogeneous group of diseases in which the anaemia is predominantly caused by dyserythropoiesis and marked ineffective erythropoiesis; three major (types I, II and III) and several minor subgroups have been identified. Additional information on the natural history of these conditions, the beneficial role of splenectomy in CDA type II and efficacy of interferon-alpha in type I have recently been reported. A disease gene has been localised to a chromosomal segment in the three major types and in CDA type I, a disease gene has been identified (CDANI). Mutations have been detected in both familial and sporadic cases but the predicted protein structure gives few clues as to its function. In both type I and II, there are cases unlinked to the identified localisations, suggesting genetic heterogeneity.
先天性红细胞生成异常性贫血(CDA)是一组异质性疾病,其中贫血主要由红细胞生成异常和显著的无效红细胞生成引起;已确定了三个主要类型(I型、II型和III型)以及几个次要亚组。最近有报道称,关于这些疾病的自然史、脾切除术在II型CDA中的有益作用以及I型中α干扰素的疗效有了更多信息。一种疾病基因已定位到三个主要类型的染色体区段,在I型CDA中,已鉴定出一种疾病基因(CDANI)。在家族性和散发性病例中均检测到突变,但预测的蛋白质结构几乎没有提供关于其功能的线索。在I型和II型中,都有一些病例与已确定的定位无关,这表明存在遗传异质性。